Navigation Links
Southern Research Institute Names Vladimir Yamshchikov Director of Infectious Disease Research Department in Birmingham
Date:11/5/2007

BIRMINGHAM, Ala., Nov. 5 /PRNewswire-USNewswire/ -- Southern Research Institute, a not-for-profit organization that conducts basic and applied research in the areas of preclinical drug discovery, drug and vaccine development, advanced engineering, environmental and energy production, today announced the appointment of Vladimir Yamshchikov, Ph.D. as director of its Infectious Disease Research Dept. in Birmingham.

(Photo: http://www.newscom.com/cgi-bin/prnh/20071105/6371)

"Dr. Yamshchikov has an impressive combination of scientific, technical and regulatory expertise, with more than 20 years experience with research in molecular virology in BSL-3 and ABSL-3 laboratories," said William R. Waud, Ph.D., interim vice president of the Drug Development Division at Southern Research. "His intimate knowledge and experience working with infectious diseases and select agents will serve him well as he manages this growing area of research at Southern Research."

Prior to joining Southern Research, Dr. Yamshchikov was an associate professor in the Department of Molecular Biosciences at the University of Kansas. He is a member of the American Society for Virology and has published more than 35 peer-reviewed research papers. He received his Master's degree in Bioorganic Chemistry from Moscow State University in Moscow, Russia and his doctorate in Bioorganic Chemistry & Molecular Biology from the Institute of Bioorganic Chemistry in Novosibirsk, Russia.

Dr. Yamshchikov has extensive experience and training in handling emerging pathogens and select agents in both BSL-3 and ABSL-3 laboratories. He also has hands-on experience working with a variety of human and veterinary pathogens and viral vectors. He spent more than 10 years managing a CDC/USDA certified BSL-3 and ABSL-3 facility approved by the FBI to handle select agents.

Southern Research also operates an Infectious Disease Research Dept. in Frederick, Md., directed by Michael G. Murray, Ph.D. Last year, Southern Research's BSL-3 laboratory in Birmingham underwent a $1 million renovation that included adding bioaerosol capabilities and expanding Southern Research's ability to conduct GLP-compliant studies in high containment, and to evaluate and test new therapeutics and vaccines to protect the public against select agents and emerging infectious diseases. The BSL-3 contains more than 8,300 square feet of in vitro and in vivo space. It is registered with the Centers for Disease Control (CDC) and the U.S. Department of Agriculture (USDA) to work with both animal and human risk group Level 3 pathogens, including highly-pathogenic avian influenza (HPAi), West Nile, SARS viruses and Bacillus anthracis (anthrax).

About Southern Research Institute

Southern Research Institute is a not-for-profit organization that conducts basic and applied research in the areas of preclinical drug discovery, vaccine and drug development, advanced engineering, environmental research and energy production. To date, Southern Research has discovered six FDA-approved cancer drugs and discovered six additional drugs that are currently in late stage preclinical and early clinical trials. No other company or institution has brought six of its own cancer drug discoveries to market. For more information, please visit http://www.southernresearch.org.


'/>"/>
SOURCE Southern Research Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
2. USAID Assistant Administrator Hess Travels to Southern Africa
3. Southern Research Institutes Neurodegenerative Disease Drug Discovery Program Receives National Institute of Mental Health Funding
4. MIT Holding, Inc. signs partnership agreement with Georgia Southern University
5. Angel Flight West Recognizes Southern California Pilots at 24th Anniversary
6. Southern California Wildfires Continue to Threaten Residential Areas
7. NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires
8. VA Remains Open for Care for Southern California Vets
9. Red Cross Receives $250,000 From Wal-Mart to Assist With Southern California Wildfire Relief Efforts
10. The Salvation Army Responds to Immediate Needs of Survivors and Relief Workers in Southern California Wildfires
11. CNA/NNOC Nurse Volunteers Deployed to Southern California Firestorm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest ... Senators Bill Cassidy (R-LA) and Lindsey ... notes that the medical device industry is in an ... device tax, the 2.3% excise tax on medical device ... they also want covered patients, increased visits and hospital ...
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017 ... , and OptiMed Specialty Pharmacy of Kalamazoo, ... offer a strategic hub service that expedites and streamlines ... personal spirometer, Spiro PD 2.0, and wellness management services.  ... is a medical device used to measure lung function ...
Breaking Medicine Technology: